NOTE (NOTE) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
19 Jan, 2026Executive summary
Q3 sales declined 22% year-over-year to SEK 809 million, with organic growth at -20% due to weaker demand and customer inventory adjustments.
Operating profit for Q3 was SEK 64 million, with an operating margin of 8% and underlying margin at 8.3% despite lower volumes.
Cash flow after investments improved to SEK 120 million in Q3, with year-to-date free cash flow at SEK 340 million, supported by inventory and accounts receivable reductions.
The company continues to invest in automation, new equipment, and facility expansions in Sweden, including capacity increases and relocations, to support anticipated future growth.
Inventory reductions of SEK 50–75 million are expected in coming quarters.
Financial highlights
Q3 net sales: SEK 809 million (down from SEK 1,034 million year-over-year); organic growth -20%.
Q3 operating profit: SEK 64 million; adjusted operating profit SEK 67 million; operating margin: 8.0% (9.1% last year).
Q3 profit after tax: SEK 43 million; EPS SEK 1.52.
Cash flow from operations was SEK 157 million in Q3 and SEK 400 million year-to-date.
Return on operating capital remained high at 23%, and equity ratio improved to 49%.
Outlook and guidance
Q4 sales are guided to be about 8% lower year-over-year, with no significant recovery expected; run rate is expected to remain flat compared to Q2 and Q3.
Q4 sales guidance: SEK 975–1,025 million; minimum operating margin of 9.5%.
Full-year 2024 guidance: sales of SEK 3.83–3.90 billion and operating margin of 8.9–9.2%.
2024 is considered a weak year, but a recovery and growth are anticipated in 2025, with long-term guidance for 2028 unchanged.
Order backlog down 3% year-over-year, reflecting shorter customer order horizons and cautious market conditions.
Latest events from NOTE
- Sales and profit fell, but margins and cash flow improved as investments support future growth.NOTE
Q2 20243 Feb 2026 - Record Q4 profitability and strategic acquisitions drive growth despite market softness.NOTE
Q4 20252 Feb 2026 - Double-digit profitability and stable growth expected, with defense and medtech leading future gains.NOTE
CMD 202411 Jan 2026 - Margins and cash flow improved as sales declined, supporting a positive 2025 outlook.NOTE
Q4 20249 Jan 2026 - Profitability and cash flow hit highs, with Security & Defence and Greentech driving growth.NOTE
Q1 202523 Dec 2025 - Strong Q2 sales and cash flow, with H2 growth expected despite FX and market headwinds.NOTE
Q2 202516 Nov 2025 - Q3 2025 saw strong growth, profitability, and a strategic UK acquisition for future expansion.NOTE
Q3 202520 Oct 2025